🔴 MetaVia is trading 6.18% down today with no clear catalyst identified

MetaVia is trading 6.18% down at $1.59, reversing its September 8 close of $1.70, with no clear catalyst identified.

• No company-specific announcement, earnings release, or clinical-trial catalyst was identified for September 9, 2026; financial coverage also reports no significant recent news.
• The latest listed corporate update was MetaVia’s August 6, 2026 second-quarter results.
• The broader market is modestly lower, but S&P 500 and Nasdaq declines are below the threshold for a strong market-wide explanation; the cause remains unclear pending further disclosures or trading-volume data.